InMed Pharmaceuticals (IN:CSE)

InMed Pharmaceuticals

inmed logoInMed Pharmaceuticals is a biopharmaceutical company that specializes in developing therapies through the research and development into the extensive pharmacology of cannabinoids coupled with innovative drug delivery systems.

InMed is utilizing its proprietary “Intelligent Cannabinoid Drug Design Platform” to identify new bioactive compounds within the cannabis plant that interact with certain genes responsible for specific diseases. These newly discovered drug candidates are developed from cannabinoids and other botanical sources significantly reduce side effects while optimizing therapeutic benefits.

  1. Momentum-350-Blue-Download
  2. Momentum-350-PPT

Signup for InMed Alerts

Please wait...

Knowledge is Power

Knowledge is a necessity for all savvy investors. To achieve great CONSISTENT returns, smart investors know they need all the information they can get. We have your information!